Trial
NCT01897454
Gemcitabine Hydrochloride, and Radiation Therapy in Patients With Borderline Resectable Pancreatic Cancer
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Albert Einstein College of Medicine
Collaborators
National Cancer Institute (NCI)
Condition
Pancreatic Adenocarcinoma
Intervention
Fluorouracil
Why stopped
Study was terminated due to slower than anticipated accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-12-05